Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

Clinical trial NCT06423781 · COMPLETED

Trial details

NCT number: NCT06423781
Sponsor: Biohaven Therapeutics Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2024-08-01
Primary completion: 2026-03-18
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.